[ad_1] TAIPEI and SAN DIEGO, Sept. 17, 2024 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), , a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that an […]
Tag: Pharmaceuticals
Viatris Announces Early Tender Results and Increase of Pending Maximum Tender Offer
[ad_1] PITTSBURGH, Sept. 17, 2024 /PRNewswire/ — Viatris Inc. (NASDAQ: VTRS, “Viatris” or the “Company”) announced today the early tender results of the previously announced cash tender offer (the “Maximum Tender Offer”) of its subsidiary […]
C3® Pharmaceuticals, Inc. Announces Upcoming Listing on the Canadian Securities Exchange
[ad_1] Manufacturer of Idrasil™, the first standardized medical cannabis, launches after 14 years of research and development, takes aim at U.S. pharmaceutical industry and its opioid epidemic. ANAHEIM, Calif., Sept. 17, 2024 /PRNewswire/ — C3 Pharmaceuticals, […]
Expanding the Bispecific Antibody Market from CAR-Ts to Drive Follicular Lymphoma’s Future
[ad_1] The competition in follicular lymphoma is rapidly intensifying, with three CAR-T therapies and three bispecific antibodies now approved for relapsed or refractory patients. As both classes of treatments expand, the battle for dominance in […]
Designación de terapia innovadora para los comprimidos sublinguales de Sanbexin
[ad_1] – Designación de terapia innovadora para los comprimidos sublinguales de Sanbexin otorgada por la Administración de Alimentos y Medicamentos de Estados Unidos NANJING, China, 16 de septiembre de 2024 /PRNewswire/ — El 2 de […]
